Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing Operations Income from Non-Controlling Interests Income towards Parent Company Interest & Investment Income Net Income towards Common Stockholders Profit After Tax Revenue Shares Outstanding Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions Tax Rate Tax Rate

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Outstanding Shares Outstanding

Ratios

HUTCHMED (China) (HCM) Shares Outstanding (2016 - 2025)

HUTCHMED (China) has reported Shares Outstanding over the past 11 years, most recently at $872.3 million for Q4 2025.

Quarterly Shares Outstanding changed 0.08% to $872.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $872.3 million through Dec 2025, changed 0.08% year-over-year, with the annual reading at $872.3 million for FY2025, 0.08% changed from the prior year.
Shares Outstanding was $872.3 million for Q4 2025 at HUTCHMED (China), roughly flat from $871.6 million in the prior quarter.
Over five years, Shares Outstanding peaked at $872.3 million in Q4 2025 and troughed at $864.5 million in Q4 2021.
The 5-year median for Shares Outstanding is $871.3 million (2023), against an average of $868.9 million.
Year-over-year, Shares Outstanding increased 18.8% in 2021 and then increased 0.03% in 2022.
A 5-year view of Shares Outstanding shows it stood at $864.5 million in 2021, then grew by 0.03% to $864.8 million in 2022, then increased by 0.75% to $871.3 million in 2023, then rose by 0.04% to $871.6 million in 2024, then grew by 0.08% to $872.3 million in 2025.
Per Business Quant, the three most recent readings for HCM's Shares Outstanding are $872.3 million (Q4 2025), $871.6 million (Q4 2024), and $871.3 million (Q4 2023).